GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Radient Technologies Inc (OTCPK:RDDTF) » Definitions » Equity-to-Asset

Radient Technologies (Radient Technologies) Equity-to-Asset : -0.54 (As of Dec. 2022)


View and export this data going back to 2016. Start your Free Trial

What is Radient Technologies Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Radient Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2022 was $-11.05 Mil. Radient Technologies's Total Assets for the quarter that ended in Dec. 2022 was $20.61 Mil. Therefore, Radient Technologies's Equity to Asset Ratio for the quarter that ended in Dec. 2022 was -0.54.

The historical rank and industry rank for Radient Technologies's Equity-to-Asset or its related term are showing as below:

RDDTF's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

Radient Technologies Equity-to-Asset Historical Data

The historical data trend for Radient Technologies's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radient Technologies Equity-to-Asset Chart

Radient Technologies Annual Data
Trend Dec13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.86 0.83 0.33 -0.09 -0.37

Radient Technologies Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.27 -0.37 -0.42 -0.49 -0.54

Competitive Comparison of Radient Technologies's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Radient Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Radient Technologies's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Radient Technologies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Radient Technologies's Equity-to-Asset falls into.



Radient Technologies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Radient Technologies's Equity to Asset Ratio for the fiscal year that ended in Mar. 2022 is calculated as

Equity to Asset (A: Mar. 2022 )=Total Stockholders Equity/Total Assets
=-7.998/21.908
=-0.37

Radient Technologies's Equity to Asset Ratio for the quarter that ended in Dec. 2022 is calculated as

Equity to Asset (Q: Dec. 2022 )=Total Stockholders Equity/Total Assets
=-11.053/20.607
=-0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Radient Technologies  (OTCPK:RDDTF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Radient Technologies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Radient Technologies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Radient Technologies (Radient Technologies) Business Description

Traded in Other Exchanges
N/A
Address
4035 101 St. NW, Edmonton, AB, CAN, T6E 0A4
Radient Technologies Inc is a Canadian company engaged in manufacturing cannabis derivatives, formulations, and products. It has developed its extraction process, Microwave Assisted Processing (MAP), which is used for producing a consistent product at industrial-scale quantities. It provides its customers and partners with white-label extracts, formulations, and finished products that contain a broad spectrum of cannabinoid and terpene profiles. While it operates in Canada and is building an additional facility in Germany. It operates in a single segment namely the production and sale of cannabis-related retail products.

Radient Technologies (Radient Technologies) Headlines